Recombinant human erythropoietin in sports: a review

Recombinant human erythropoietin in sports: a review

Erythropoietin is an endogenous hormone of glicoproteic nature secreted by the kidneys and is the main regulator of the erythropoiesis. An alteration in its production generates a disturbance in the plasmatic concentration giving rise to several types of pathologies related to the hematopoietic syst...

Full description

Bibliographic Details
Main Authors:	Rafael Maia de Almeida Bento, Lúcia Menezes Pinto Damasceno, Francisco Radler de Aquino Neto
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina do Esporte 2003-06-01
Series:	Revista Brasileira de Medicina do Esporte
Subjects:	Erythropoietin Epoetin Peptidic hormones Doping control
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1517-86922003000300006

Similar Items

Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
by: Anna Thawanny Gadelha Moura, et al.

Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon® and Eprex® following a single subcutaneous administration in healthy male volunteers
by: Yoon S, et al.
Published: (2017-10-01)

ERYTHROPOIETIN AS DOPING AGENT
by: Nina Đukanović, et al.
Published: (2012-09-01)

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
by: Maoujoud O, et al.
Published: (2016-02-01)

Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study
by: Hidehiro Tabata, et al.
Published: (2019-06-01)

A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient
by: Jaime S. Rosa, et al.
Published: (2018-03-01)

Effect of erythropoietin in treatment of renal anemia in a sample of Iraqi patient
by: Ali J. Hashim Al Saedi, et al.
Published: (2021-01-01)

The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008)

The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008)

Erythropoietin between therapy and doping : Two sides of the same coin
by: Ostojić Ana, et al.
Published: (2016-01-01)

Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis
by: Paulo D. Picon, et al.
Published: (2014-08-01)

RATIONAL SUPPORTIVE THERAPY FOR CHEMOTHERAPY INDUCED ANEMIA: A PHARMACO-ECONOMIC ANALYSIS OF ERYTHROPOIETIN THERAPY IN CANCER PATIENTS IN RUSSIAN FEDERATION
by: V. B. Larionova, et al.
Published: (2018-07-01)

Investigation of purification process stresses on erythropoietin peptide mapping profile
by: Mina Sepahi, et al.
Published: (2015-01-01)

Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
by: Losem C, et al.
Published: (2017-02-01)

The role of recombinant Human erythropoietin in neonatal anemia
by: Dalia M. El-Lahony, et al.
Published: (2020-09-01)

Influence of Erythropoietin Dose and Albumin Level on the Plasma Brain Natriuretic Peptide in Hemodialysis Patients
by: Alsuwaida Abdulkareem
Published: (2006-01-01)

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
by: Gilbertson David T, et al.
Published: (2013-02-01)

"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-05-01)

"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-04-01)

Resistance to recombinant human erythropoietin therapy in haemodialysis patients
by: Elísio Costa, et al.
Published: (2009-06-01)

Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
by: A. M. Kudryashova, et al.
Published: (2020-01-01)

Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01)

O papel do atleta na sociedade e o controle de dopagem no esporte The athlete's role in society and doping control in sports
by: Francisco Radler de Aquino Neto
Published: (2001-08-01)

Use of Recombinant Human Erythropoietin in Renal Anemia in Children
by: Habibur Rahman, et al.
Published: (2009-11-01)

THE ROLE OF ERYTHROPOIETIN IN TREATMENT OF ANEMIA IN CANCER PATIENTS
by: P. G. Berezin, et al.
Published: (2017-06-01)

Erythropoietin and Its Angiogenic Activity
by: Patrícia Kimáková, et al.
Published: (2017-07-01)

The bloodloss: effect on the erythropoetic activity of the red bone marrow of rats on the use of recombinant erythropoietin
by: Vasilchenko V.V., et al.
Published: (2007-01-01)

Erythropoietin use and abuse
by: M Joseph John, et al.
Published: (2012-01-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

Characterisation of Recombinant Human Erythropoietin Obtained from CHOpE—Erythropoietin Producing Strain of Chinese Hamster Ovary Cells
by: I. F. Radaeva, et al.
Published: (2020-06-01)

Cloning and expression of human recombinant erythropoietin in Leishmania tarentolae
by: Kianmehr A, et al.
Published: (2014-07-01)

Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours
by: Gonçalo dos Santos Clemente, et al.
Published: (2011-03-01)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
by: Carolina Castillo Hernández, et al.
Published: (2017-01-01)

STAT5 as a Key Protein of Erythropoietin Signalization
by: Zuzana Tóthová, et al.
Published: (2021-07-01)

Paraneoplastic Erythropoietin Secreting Tumor of Renal Origin: A Forgotten Endocrine Hormone
by: Yaseen Ali, et al.
Published: (2015-09-01)

Proof of Gene Doping in a Mouse Model with a Human Erythropoietin Gene Transferred Using an Adenoviral Vector
by: Takehito Sugasawa, et al.
Published: (2021-08-01)

Association of I/D angiotensin-converting enzyme genotype with erythropoietin stimulation in kidney failure
by: Savin Marina, et al.
Published: (2017-01-01)

Acquired pure red cell aplasia and recombinant erythropoietin
by: Somanath Padhi, et al.
Published: (2021-01-01)

CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS
by: V. D. Nazarov, et al.
Published: (2018-01-01)

Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K⁄Akt pathway
by: Zhi-Kun Sun, et al.
Published: (2012-02-01)